MARKET

AMRN

AMRN

Amarin
NASDAQ
1.120
-0.050
-4.27%
Pre Market: 1.160 +0.04 +3.57% 08:00 11/29 EST
OPEN
1.150
PREV CLOSE
1.170
HIGH
1.190
LOW
1.120
VOLUME
20
TURNOVER
--
52 WEEK HIGH
3.815
52 WEEK LOW
1.040
MARKET CAP
452.29M
P/E (TTM)
-4.8069
1D
5D
1M
3M
1Y
5Y
Eurozone PMI Data Supports European Equities
Eurozone PMI Data Supports European Equities
MT Newswires · 6d ago
Why Amarin (AMRN) Stock Might be a Great Pick
Amarin (AMRN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Zacks · 11/21 13:42
Amarin wins regulatory nod in Australia for heart disease therapy
Seekingalpha · 11/15 12:51
Amarin Says Australia Approves Cardiovascular Drug Vazkepa
Amarin Says Australia Approves Cardiovascular Drug Vazkepa
MT Newswires · 11/15 09:28
Amarin to Present at Jefferies London Healthcare Conference
DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Karim Mikhail, Amarin’s president and chief executive officer, is scheduled to participate at the Jefferies London Healthcare...
GlobeNewswire · 11/09 13:00
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
Benzinga · 11/08 10:00
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
Benzinga · 11/07 17:46
Amarin adds 13% as independent study supports heart disease therapy
Seekingalpha · 11/07 17:28
More
About AMRN
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics for cardiovascular disease management. The Company operates through the development and commercialization of Vascepa segment. Its lead product, Vascepa (icosapent ethyl) capsule for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

Webull offers kinds of Amarin Corporation plc (ADR) stock information, including NASDAQ:AMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMRN stock methods without spending real money on the virtual paper trading platform.